Sonoma Pharmaceuticals

SNOA78

High Growth

$3.91arrow_drop_up11.71%$0.41

High Growth

Penny Stock

SNOA78

$3.91

arrow_drop_up11.71%$0.41

High Growth

Penny Stock

Performance History

Key Stats
Open	$3.64
Prev. Close	$3.50
EPS	-6.20
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$3.59M
PE Ratio	-

	LOW	HIGH
Day Range	3.64	3.64
52 Week Range	2.40	19.00

Ratios

Revenue	-





EPS	-6.20

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Sonoma Pharmaceuticals (SNOA)

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company that develops and markets unique and effective solutions for dermatological conditions and advanced tissue care. The company is focused on bringing innovative therapies to patients and healthcare professionals around the world. Sonoma Pharmaceuticals has a diverse product portfolio that includes prescription and over-the-counter medications, as well as advanced wound care products. Their products are designed to treat a wide range of conditions, including acne, rosacea, eczema, and various types of wounds. Sonoma Pharmaceuticals is committed to delivering safe, effective, and high-quality solutions that improve patient outcomes. They have a strong track record of success and are well-positioned for future growth.

Sonoma Pharmaceuticals Inc's stock price history reflects the company's strong performance and positive outlook. The stock has shown steady growth over the years, with periodic fluctuations that are typical for the pharmaceutical industry. The company's commitment to innovation and its ability to meet the needs of patients and healthcare professionals have contributed to its success. Sonoma Pharmaceuticals Inc's stock quote provides investors with real-time trading updates and market data. Investors can track the stock's performance and make informed decisions based on the latest information. Sonoma Pharmaceuticals Inc's stock news covers recent developments and announcements from the company. This includes information on new product launches, partnerships, and regulatory updates. The news helps investors stay informed about the company's progress and potential future opportunities. Sonoma Pharmaceuticals Inc's stock analysis provides detailed insights into the company's financial performance, market position, and growth prospects. Analysts evaluate various factors, including revenue, earnings, market trends, and competitive landscape, to assess the stock's potential. This analysis helps investors understand the company's strengths and weaknesses and make informed investment decisions. Sonoma Pharmaceuticals Inc's smart analysis combines advanced data analytics and artificial intelligence to provide in-depth insights into the stock's performance and market trends. The smart analysis uses sophisticated algorithms to analyze large volumes of data and generate actionable recommendations. It helps investors identify patterns and trends that may impact the stock's future performance. Sonoma Pharmaceuticals Inc's market cap reflects the total market value of the company's outstanding shares. It is calculated by multiplying the stock's current price by the total number of shares. Sonoma Pharmaceuticals Inc's market cap provides investors with an indication of the company's size and value in the market. The PEG ratio is a valuation metric that compares a company's price-to-earnings ratio (P/E ratio) to its expected earnings growth rate. Sonoma Pharmaceuticals Inc's PEG ratio helps investors assess the stock's valuation relative to its growth potential. A PEG ratio below 1 is generally considered undervalued, while a ratio above 1 may indicate overvaluation. Sonoma Pharmaceuticals Inc's performance can be evaluated in comparison to its industry peers. This includes assessing the stock's financial metrics, market share, and competitive positioning. Sonoma Pharmaceuticals Inc's 52-week range reflects the highest and lowest prices at which the stock has traded over the past year. It provides investors with an indication of the stock's price volatility and potential trading range. Sonoma Pharmaceuticals Inc's day range indicates the highest and lowest prices at which the stock has traded during the current trading session. It helps investors assess intraday trading patterns and volatility. Sonoma Pharmaceuticals Inc's trading volume refers to the total number of shares traded during a specified period. It provides insights into the stock's liquidity and investor interest. High trading volume may suggest increased investor activity and potential price volatility.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Ms. Amy M. Trombly
Headquarters: Boulder
Employees: 9
Exchange: NASDAQ

Keep an eye on Sonoma Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Sonoma Pharmaceuticals 's (SNOA) price per share?

The current price per share for Sonoma Pharmaceuticals (SNOA) is $3.91. The stock has seen a price change of $0.41 recently, indicating a 11.71% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Sonoma Pharmaceuticals (SNOA)?

For Sonoma Pharmaceuticals (SNOA), the 52-week high is $19, which is 385.93% from the current price. The 52-week low is $2.4, the current price is 62.92% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Sonoma Pharmaceuticals (SNOA) a growth stock?

Sonoma Pharmaceuticals (SNOA) has shown an average price growth of 0.41% over the past three years. It has received a score of -2 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Sonoma Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Sonoma Pharmaceuticals (SNOA) stock price performance year to date (YTD)?

As of the latest data, Sonoma Pharmaceuticals (SNOA) has a year-to-date price change of 7.42%. Over the past month, the stock has experienced a price change of -16.77%. Over the last three months, the change has been 16.02%. Over the past six months, the figure is 42.39%. Looking at a longer horizon, the five-year price change stands at -97.04%.

help

Is Sonoma Pharmaceuticals (SNOA) a profitable company?

Sonoma Pharmaceuticals (SNOA) has a net income of -$4.84M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 37.26% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -34.59% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $4.74M. Operating income is noted at -$4.7M. Furthermore, the EBITDA is -$4.46M.

help

What is the market capitalization of Sonoma Pharmaceuticals (SNOA)?

Sonoma Pharmaceuticals (SNOA) has a market capitalization of $3.59M. The average daily trading volume is 52.57K, indicating the stock's liquidity and investor engagement.